Cargando…

Soluble Fas and the −670 Polymorphism of Fas in Lupus Nephritis

This study was performed to clarify the role of soluble Fas (sFas) in lupus nephritis (LN) and establish a potential relationship between LN and the −670 polymorphism of Fas in 67 patients with systemic lupus erythematosus (SLE), including a subset of 24 LN patients with proteinuria. Additionally, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bollain-y-Goytia, Juan José, Arellano-Rodríguez, Mariela, Torres-Del-Muro, Felipe de Jesús, Daza-Benítez, Leonel, Francisco Muñoz-Valle, José, Avalos-Díaz, Esperanza, Herrera-Esparza, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251877/ https://www.ncbi.nlm.nih.gov/pubmed/25505993 http://dx.doi.org/10.1155/2014/780406

Ejemplares similares

suPAR and WT1 modify the adhesion of podocytes and are related to proteinuria in class IV lupus nephritis
por: Bollain-y-Goytia, Juan-José, et al.
Publicado: (2023)

Increased excretion of urinary podocytes in lupus nephritis
por: Bollain-y-Goytia, J. J., et al.
Publicado: (2011)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2020)

Stronger Correlation between Interleukin 18 and Soluble Fas in Lupus Nephritis Compared with Mild Lupus
por: Hatef, Mohammad Reza, et al.
Publicado: (2013)

Lupus in the Fas Lane?
por: Singh, Ajay K
Publicado: (1995)

An Animal Model Using Metallic Ions to Produce Autoimmune Nephritis
por: Ramírez-Sandoval, Roxana, et al.
Publicado: (2015)

Apoptosis and Redistribution of the Ro Autoantigen in Balb/c Mouse Like in Subacute Cutaneous Lupus Erythematosus
por: Herrera-Esparza, Rafael, et al.
Publicado: (2006)

Association of FAS and FAS Ligand Genes Polymorphism and Risk of Systemic Lupus Erythematosus
por: Moudi, Bita, et al.
Publicado: (2013)

Fas-670A>G polymorphism is not associated with an increased risk of acute myeloid leukemia development
por: HUANG, YING, et al.
Publicado: (2016)

Elevated Concentrations of Soluble Fas and FasL in Multiple Sclerosis Patients with Antinuclear Antibodies
por: Sremec, Josip, et al.
Publicado: (2020)

Cytoplasmic Localization of WT1 and Decrease of miRNA-16-1 in Nephrotic Syndrome
por: Zapata-Benavides, Pablo, et al.
Publicado: (2017)

Plasma concentrations of soluble Fas receptors (Fas) and Fas ligands (FasL) in relation to CD4+ cell counts in HIV-1 positive and negative patients in Yaounde, Cameroon
por: Ikomey, George M, et al.
Publicado: (2012)

Matrix metalloproteinase-1, soluble Fas ligand, and soluble Fas antigen levels in patients with multiple organ dysfunction syndrome
por: Endo, S, et al.
Publicado: (1998)

The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
por: Henkler, Frank, et al.
Publicado: (2005)

An Activin Receptor IA/Activin-Like Kinase-2 (R206H) Mutation in Fibrodysplasia Ossificans Progressiva
por: Herrera-Esparza, Rafael, et al.
Publicado: (2013)

Family Aggregation of HTLV-1 Infection Associated with FAS -670A/G Polymorphism: A Case Report
por: Vallinoto, Antonio C. R., et al.
Publicado: (2018)

Membrane Fas Ligand Kills Human Peripheral Blood T Lymphocytes, and Soluble Fas Ligand Blocks the Killing
por: Suda, Takashi, et al.
Publicado: (1997)

Enhancing Production and Cytotoxic Activity of Polymeric Soluble FasL-Based Chimeric Proteins by Concomitant Expression of Soluble FasL
por: Morello, Aurore, et al.
Publicado: (2013)

Role of Fas and Treg Cells in Fracture Healing as Characterized in the Fas-Deficient (lpr) Mouse Model of Lupus†
por: Al-Sebaei, Maisa O, et al.
Publicado: (2014)

Posttranslational Protein Modification in the Salivary Glands of Sjögren's Syndrome Patients
por: Herrera-Esparza, Rafael, et al.
Publicado: (2013)

Deletion of Mir223 Exacerbates Lupus Nephritis by Targeting S1pr1 in Fas(lpr/lpr) Mice
por: Hiramatsu-Asano, Sumie, et al.
Publicado: (2021)

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
Publicado: (1996)

Tracking the Prevalence of FAS
por: Cordero, José F., et al.
Publicado: (1994)

Understanding the role of Fas-Fas ligand system in bone
por: Marusic, Ana, et al.
Publicado: (2012)

Differential expressions of Fas and Fas ligand in human placenta.
por: Roh, Cheong-Rae, et al.
Publicado: (2002)

The Fas/FasL System in Reproduction: Survival and Apoptosis
por: Mor, Gil, et al.
Publicado: (2002)

Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis
por: Kim, Wan-Uk, et al.
Publicado: (2007)

Circulating soluble Fas levels and risk of ovarian cancer
por: Akhmedkhanov, Arslan, et al.
Publicado: (2003)

Soluble Fas Ligand Is Essential for Blister Formation in Pemphigus
por: Lotti, Roberta, et al.
Publicado: (2018)

Multiple autoimmunity and epitope spreading in monozygotic twins
por: Avalos-Díaz, Esperanza, et al.
Publicado: (2021)

Matrix metalloproteinases and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis
por: Musiał, Kinga, et al.
Publicado: (2011)

Association of FAS -670A/G and FASL –843C/T Gene Polymorphisms on Allograft Nephropathy in Pediatric Renal Transplant Patients
por: Ertan, Pelin, et al.
Publicado: (2010)

Fas and Fas Ligand Interactions Suppress Melanoma Lung Metastasis
por: Owen-Schaub, Laurie B., et al.
Publicado: (1998)

Apoptosis role of FAS/FAS ligand system in the regulation of myelopoiesis.
por: Alenzi, Faris Q., et al.
Publicado: (2005)

Role of the Fas/FasL pathway in HIV or SIV disease
por: Poonia, Bhawna, et al.
Publicado: (2009)

Prognostic value of the Fas/Fas ligand system in breast cancer
por: Bębenek, Marek, et al.
Publicado: (2013)

Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis
por: Volpe, Elisabetta, et al.
Publicado: (2016)

Dynamic Changes of Soluble Fas and IL-2/IL-10 in serum and Fas Expression in Lung in the Rats of Acute Necrotizing Pancreatitis
por: Zhang, Jian Xin, et al.
Publicado: (2008)

Elevated Soluble Fas and FasL in Cerebrospinal Fluid and Serum of Patients With Anti-N-methyl-D-aspartate Receptor Encephalitis
por: Ding, Yue-Wen, et al.
Publicado: (2018)

Levels of soluble Fas/APO-1 in patients with Behçet's disease.
por: Hamzaoui, K, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_kfhc0a6p9cdl9n570mm5nm6ncs